In 2000, Perou and Sorlie reported that breast cancer could be divided into three subtypes according to the enrichment of three genes, luminal (estrogen receptor [ER]-positive), human epidermal growth factor receptor 2 (HER2, encoded by ERBB2)-positive and ER-negative, and basal subtypes3. Here, ESR1 is linked to breast cancer.